Indications for use: Treatment of symptoms of moderate and severe benign prostatic hyperplasia; reducing the risk of acute urinary retention and the need for surgical intervention in patients with moderate and severe symptoms of benign prostatic hyperplasia.

Contraindication: Prostid is contraindicated in patients with hypersensitivity to dutasteride, other 5a-reductase inhibitors, soy, peanut or other components of the drug.

Prostid should not be used to treat women and children (see section "Use during pregnancy or breastfeeding").

Prostid is contraindicated in patients with severe hepatic impairment.